Neurite density is reduced in the presymptomatic phase ofC9orf72disease

Junhao Wen, Hui Zhang, Daniel C. Alexander, Stanley Durrleman, Alexandre Routier, Daisy Rinaldi, Marion Houot, Philippe Couratier, Didier Hannequin, Florence Pasquier, Jiaying Zhang, Olivier Colliot, Isabelle Le Ber, Anne BertrandJournal of Neurology Neurosurgery & Psychiatry 2018 · DOI

TL;DR

This study reveals that neurite density, a measure of neuronal connections, is reduced in the brains of individuals who carry the C9orf72 gene mutation but have not yet developed symptoms. Using a novel imaging technique called NODDI, researchers demonstrated higher sensitivity in detecting these subtle white matter changes compared to traditional methods, suggesting NODDI could be a valuable tool for early diagnosis and tracking disease progression.

What Problem Does This Paper Address?

Frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) are devastating neurodegenerative diseases that share a common genetic cause: a specific repeat expansion in the C9orf72 gene. Early detection of these diseases is crucial for developing effective treatments, especially since presymptomatic carriers represent an ideal population for clinical trials. While anatomical MRI has shown some brain atrophy in these individuals, and diffusion tensor imaging (DTI) has hinted at white matter integrity disruptions, these methods have limitations. DTI metrics like fractional anisotropy (FA) are not specific to particular microstructural changes, and DTI can be affected by image artifacts. This paper addresses the need for more sensitive and specific imaging techniques to identify the earliest signs of C9orf72-related neurodegeneration in the presymptomatic stage.

Methods

The researchers employed a multi-shell diffusion MRI sequence to acquire data for both conventional DTI and a more advanced technique called Neurite Orientation Dispersion and Density Imaging (NODDI). NODDI is designed to provide more specific information about the brain's white matter microstructure by quantifying two key parameters: neurite density index (NDI) and orientation dispersion index (ODI). NDI reflects the density of neuronal processes (axons and dendrites), while ODI measures how these processes are oriented relative to each other. The study also included anatomical MRI (3DT1) for volumetric analysis and free water fraction (FWF) estimation.

The data from 38 presymptomatic C9orf72 mutation carriers (C9+) and 29 non-carriers (C9-) were analyzed using linear mixed-effects models to compare white matter integrity, gray matter volume, and FWF. The key innovation here is the direct comparison of NODDI's performance against DTI and anatomical MRI in this specific presymptomatic population.

Datasets

The study utilized data from the PREV-DEMALS (Predict to Prevent Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis) study. This was a prospective, multicenter, observational study that enrolled 86 first-degree relatives of individuals with the C9orf72 mutation. For this specific cross-sectional study, 67 neurologically healthy participants (38 C9+ carriers and 29 C9- non-carriers) underwent MRI scans. No new benchmark datasets were introduced.

Key Insights and Ideas

  • Neurite density is an early casualty: The most striking finding is that reduced neurite density (NDI) appears to be a primary microstructural change in the presymptomatic stage of C9orf72 disease, preceding more generalized white matter integrity disruptions detected by DTI.
  • NODDI's superior sensitivity: NODDI significantly outperformed DTI in detecting white matter abnormalities in the presymptomatic C9orf72 carriers, identifying changes in more tracts and showing larger effect sizes in some key areas.
  • Specificity matters: The greater tissue-specificity of NODDI suggests that the observed changes are directly related to the loss of neuronal connections, rather than more general alterations in water diffusion that DTI measures.
  • Complementary information from FWF: Free water fraction (FWF) provided complementary information to volumetric measures in gray matter, highlighting distinct patterns of alteration in cortical and subcortical structures.

Key Results

  • NODDI detected white matter abnormalities in 10 tracts, while DTI metrics (MD, AD, or RD) only identified changes in 5 tracts.
  • The effect size for NDI was significantly higher than for DTI metrics in two tracts: the left inferior fronto-occipital fasciculus and the right uncinate fasciculus.
  • No tract showed a significantly higher effect size for DTI compared to NODDI.
  • In cortical gray matter analysis, FWF showed alterations in 13 regions, while volumetry identified changes in 11 regions.
  • The left insula, lateral occipital cortex, and left pericalcarine cortex showed significantly higher effect sizes with FWF compared to volumetry.
  • Subcortical analysis revealed a reduction in the volume of the right thalamus, but FWF did not detect significant alterations in this region.

Limitations and Future Work

The authors acknowledge a few limitations:

  • Cross-model comparison: The comparison between NODDI and DTI used two different DWI acquisitions performed sequentially within a week. While optimized for each model, this could introduce variability.
  • Cortical analysis challenges: Diffusion MRI-based cortical analysis is inherently challenging due to the thin structure of the cortex and potential partial volume effects from cerebrospinal fluid (CSF). Despite implementing specific processing steps, FWF estimates might still be impacted.
  • Lack of test-retest reliability: The study did not include test-retest scans, so direct assessment of NODDI's reliability within this cohort was not possible, though prior studies have shown excellent reproducibility.

The authors encourage the use of multi-shell DWI sequences and NODDI in future clinical studies to track presymptomatic neurodegenerative disease progression. Future work could focus on longitudinal studies to confirm these findings and explore the predictive value of NODDI for disease onset and progression. Further investigation into the specific mechanisms underlying neurite density loss in C9orf72 carriers, potentially through histological correlation, is also warranted.

Summary updated

Abstract

NCT02590276.
BibTeX
@article{wen2018neurite,
  author = {Junhao Wen and Hui Zhang and Daniel C. Alexander and Stanley Durrleman and Alexandre Routier and Daisy Rinaldi and Marion Houot and Philippe Couratier and Didier Hannequin and Florence Pasquier and Jiaying Zhang and Olivier Colliot and Isabelle Le Ber and Anne Bertrand},
  title = {{Neurite density is reduced in the presymptomatic phase of<i>C9orf72</i>disease}},
  journal = {Journal of Neurology Neurosurgery \& Psychiatry},
  year = {2018},
  doi = {10.1136/jnnp-2018-318994},
}
Figure